Search for the latest oncology news by tumour type
A new treatment for breast cancer patients with hormone receptor (HR+) early stage disease who…
Almost half of patients who received a targeted drug during treatment for newly diagnosed BRCA-mutated…
The CHRYSALIS study (NCT02609776) is evaluating amivantamab, a fully human bispecific antibody that targets epidermal…
Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and…
Results from the PROfound phase III study, funded by AstraZeneca and Merck Sharp & Dohme,…
Adding abemaciclib to hormonal therapy reduces the risk of cancer recurrence by 25% in patients…
The results from the confirmatory Phase 3 ASCENT study have been announced showing that sacituzumab…
The results of the phase 3 CheckMate 9ER trial have provided a new first-line treatment…
Breast cancer patients whose disease has spread to their brains fare better if their metastases…
Immunotherapy drug avelumab has been shown to significantly improve survival in patients with the most…